Search

Search Results

• Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis

  G.E. Carpagnano, P. Carratù, M. Gelardi, A. Spanevello, G. Di Gioia, T. Condreva, O. Resta, M.P. Foschino Barbaro

  2016-01-25

  https://doi.org/10.4081/monaldi.2009.369

  979

  PDF: 570

• Chronic rhinosinusitis with nasal polyps: 64 pheno-endotypes for personalized therapy. Time to change the paradigm

  Matteo Gelardi

  2025-12-19

  https://doi.org/10.4081/monaldi.2025.3645

  425

  PDF_EARLY VIEW: 172
• 

  COVID-19: the difference between the nose and the lung

  Matteo Gelardi, Mario Notargiacomo, Eleonora Maria Consiglia Trecca, Michele Cassano, Giorgio Ciprandi

  2021-03-05

  https://doi.org/10.4081/monaldi.2021.1708

  1684

  PDF: 769
• 

  Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice

  Matteo Gelardi, Giuseppe Porro, Vitaliano Quaranta, Nicola Quaranta, Michele Cassano, Giorgio Ciprandi, *Italian Study Group on CRSwNP

  2020-06-23

  https://doi.org/10.4081/monaldi.2020.1277

  2415

  PDF: 1296

• Italian survey on the effectiveness of halotherapy administered via the Aerosal^® system

  Matteo Gelardi, Rossana Giancaspro, Francesca Fortunato, Michele Cassano

  2024-08-29

  https://doi.org/10.4081/monaldi.2024.3007

  2055

  PDF: 256
• 

  Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine

  Giorgio Ciprandi, Matteo Gelardi

  2021-03-08

  https://doi.org/10.4081/monaldi.2021.1769

  2406

  PDF: 1190